FCGR1A and leprosy: These patients exhibit compromised cellular immunity yet retain adequate quantities of B lymphocytes and plasma cells, enabling them to generate antibodies targeting M. leprae. Indeed, the methodology adopted found that circulating neutrophil CD64 expression could provide a rapid and non-invasive ENL diagnosis capable of detecting reactions in outpatient clinics as well as leprosy reference centers, leading to more effective therapeutic decisions.